{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:12:13Z","timestamp":1758478333420},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[1997,5]]},"DOI":"10.1007\/bf03160578","type":"journal-article","created":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T02:31:51Z","timestamp":1251167511000},"page":"S26-S29","source":"Crossref","is-referenced-by-count":14,"title":["Health outcome and quality-of-life measurements in amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"244","author":[{"given":"Michael","family":"Swash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03160578_CR1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM199603283341306","volume":"334","author":"MA Testa","year":"1996","unstructured":"Testa MA, Simonson DC (1996) Assesment of quality-of-life outcomes. N Engl J Med 334: 835\u2013840","journal-title":"N Engl J Med"},{"key":"BF03160578_CR2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4471-1871-8","volume-title":"Motor\u2019 neuron disease: biology and management","author":"PN Leigh","year":"1995","unstructured":"Leigh PN, Swash M (1995) Motor\u2019 neuron disease: biology and management. Springer, London Berlin Heidelberg"},{"key":"BF03160578_CR3","volume-title":"Quality of life assessments in clinical trials","author":"B Spilker","year":"1990","unstructured":"Spilker B (1990) Quality of life assessments in clinical trials. Raven, New York"},{"key":"BF03160578_CR4","volume-title":"Measuring health; a guide to rating scales and questionnaires","author":"I McDowell","year":"1996","unstructured":"McDowell I, Newell C (1996) Measuring health; a guide to rating scales and questionnaires, 2nd edn. Oxford University Press, Oxford","edition":"2nd edn"},{"key":"BF03160578_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0733-8619(05)70264-4","volume":"14","author":"BR Brooks","year":"1966","unstructured":"Brooks BR (1966) Clinical epidemiology of amyotrophic lateral sclerosis. Neurol Clin 14: 399\u2013420","journal-title":"Neurol Clin"},{"key":"BF03160578_CR6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","volume":"347","author":"L Lacomblez","year":"1996","unstructured":"Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V, for the Amyotrophic Lateral Sclerosis Study Group II (1996) Dose ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347: 1425\u20131431","journal-title":"Lancet"},{"key":"BF03160578_CR7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(96)03181-9","volume":"348","author":"J Wokke","year":"1996","unstructured":"Wokke J (1996) Riluzole. Lancet 348: 795\u2013799","journal-title":"Lancet"},{"key":"BF03160578_CR8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","volume":"43","author":"The IFN\u03b2 Multiple Sclerosis Study Group","year":"1993","unstructured":"The IFN\u03b2 Multiple Sclerosis Study Group (1993) Interferon b 1\u03b2 is effective in relapsing-remitting multiple sclerosis. 1. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655\u2013661","journal-title":"Neurology"},{"key":"BF03160578_CR9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.410400321","volume":"40","author":"R Rudick","year":"1996","unstructured":"Rudick R, Antel J, Confraveux C, et al (1996) Clinical outcomes assessment in multiple sclerosis. Ann Neurol 40: 469\u2013479","journal-title":"Ann Neurol"},{"key":"BF03160578_CR10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jme.10.3.124","volume":"10","author":"KE Calman","year":"1984","unstructured":"Calman KE (1984) Quality of life in concepts; a hypothesis. J Med Ethics 10: 124\u2013127","journal-title":"J Med Ethics"},{"key":"BF03160578_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.60.2.127","volume":"60","author":"JC Hobart","year":"1996","unstructured":"Hobart JC, Lamping DL, Thompson AJ (1996) Evaluating neurological outcome measures: the bare essentials. J Neurol Neurosurg Psychiatry 60: 127\u2013130","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF03160578_CR12","volume-title":"SF-36 physical and mental health summary scores: a user\u2019s manual","author":"JE Ware","year":"1994","unstructured":"Ware JE Jr, Kosinski M, Keller SD (1994) SF-36 physical and mental health summary scores: a user\u2019s manual. The Health Institute, New England Medical Center, Boston, Mass"},{"key":"BF03160578_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02260863","volume":"4","author":"V Peto","year":"1995","unstructured":"Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and wellbeing for individuals with Parkinson\u2019s disease. Qual Life Res 4: 241\u2013248","journal-title":"Qual Life Res"},{"key":"BF03160578_CR14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ageing\/24.6.505","volume":"24","author":"C Jenkinson","year":"1995","unstructured":"Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N (1995) Self-reported functioning and well-being in patients with Parkinson\u2019s disease: comparison of the short-form Health Survey (SF-36) and the Parkinson\u2019s Disease Questionnaire (PDQ-39). Age Ageing 24: 505\u2013509","journal-title":"Age Ageing"},{"key":"BF03160578_CR15","unstructured":"Hunt SM, McKenna SP, McEwen J (1989) The Nottingham Health Profile: User\u2019s Manual, revised edn. Manchester University"},{"key":"BF03160578_CR16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.305.6854.645-b","volume":"305","author":"SM Hunt","year":"1992","unstructured":"Hunt SM, McKenna SP (1992) Validating the SF-36. BMJ 305: 645","journal-title":"BMJ"},{"key":"BF03160578_CR17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/geronj\/38.3.344","volume":"38","author":"BC Robinson","year":"1983","unstructured":"Robinson BC (1983) Validation of a caregiver strain index. J Gerontol 38: 351\u2013353","journal-title":"J Gerontol"},{"key":"BF03160578_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archneur.1996.00550020045014","volume":"53","author":"ALS CNTF Treatment Study (ACTS) Phase I\u2013II Study Group","year":"1996","unstructured":"ALS CNTF Treatment Study (ACTS) Phase I\u2013II Study Group (1996) The amyotrophic lateral sclerosis functional rating scale; assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 53: 141\u2013147","journal-title":"Arch Neurol"},{"key":"BF03160578_CR19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0022-510X(93)90245-T","volume":"118","author":"F Norris","year":"1993","unstructured":"Norris F, Shepherd R, Denys E, et al (1993) Onset, natural history and outcome in idiopathic motor neuron disease. J Neurol Sci 118: 48\u201355","journal-title":"J Neurol Sci"},{"key":"BF03160578_CR20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/118.3.707","volume":"118","author":"LJ Haverkamp","year":"1995","unstructured":"Haverkamp LJ, Appel V, Appel SH (1995) Natural history of amyotrophic lateral sclerosis in a database population. Brain 118: 707\u2013719","journal-title":"Brain"},{"key":"BF03160578_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005650-197601000-00006","volume":"14","author":"JL Bergner","year":"1976","unstructured":"Bergner JL, Bobbitt RA, Pollard W, Martin DP, Gilson BS (1976) The Sickness Impact Profile; validation of a health status measure. Med Care 14: 57\u201367","journal-title":"Med Care"},{"key":"BF03160578_CR22","volume-title":"Introduction to research in health services","author":"J Polgar","year":"1991","unstructured":"Polgar J, Thomas V (1991) Introduction to research in health services. Churchill-Livingstone, Edinburgh"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03160578.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03160578\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03160578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T02:36:19Z","timestamp":1558492579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03160578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":22,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["BF03160578"],"URL":"https:\/\/doi.org\/10.1007\/bf03160578","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}